These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3967090)

  • 61. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A single-step method for the isolation of antithrombin III.
    Wickerhauser M; Williams C
    Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antithrombin BM from human plasma: an antithrombin binding moderately to heparin.
    Wunderwald P; Schrenk WJ; Port H
    Thromb Res; 1982 Feb; 25(3):177-91. PubMed ID: 6175043
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purification and characterization of rat adipose tissue lipoprotein lipase.
    Parkin SM; Speake BK; Robinson DS
    Biochem J; 1982 Dec; 207(3):485-95. PubMed ID: 7165705
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.
    Girolami A; Fabris F; Cappellato G; Sainati L; Boeri G
    Blut; 1983 Aug; 47(2):93-103. PubMed ID: 6871478
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Investigations on antithrombin III in normal plasma and serum.
    Sas G; Pepper DS; Cash JD
    Br J Haematol; 1975 Jul; 30(3):265-72. PubMed ID: 1201212
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antithrombin-III Denver, a reactive site variant.
    Stephens AW; Thalley BS; Hirs CH
    J Biol Chem; 1987 Jan; 262(3):1044-8. PubMed ID: 3805013
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography.
    Lebing WR; Hammond DJ; Wydick JE; Baumbach GA
    Vox Sang; 1994; 67(2):117-24. PubMed ID: 7801599
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Abnormal properties and behaviors of antithrombin III found in a thrombophilic patient: defective biological functions and dissimilar antigenic determinants.
    Murayama H; Matsuda M
    Thromb Haemost; 1986 Oct; 56(2):165-71. PubMed ID: 3101219
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding.
    Peterson CB; Blackburn MN
    J Biol Chem; 1985 Jan; 260(1):610-5. PubMed ID: 3965464
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antithrombin III Budapest: a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family.
    Olds RJ; Lane DA; Caso R; Panico M; Morris HR; Sas G; Dawes J; Thein SL
    Blood; 1992 Mar; 79(5):1206-12. PubMed ID: 1536946
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin.
    Girolami A; Marafioti F; Rubertelli M; Vicarioto MA; Cappellato G; Mazzuccato M
    Acta Haematol; 1984; 72(2):73-82. PubMed ID: 6208738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The covalent nature of the human antithrombin III--thrombin bond.
    Longas MO; Finlay TH
    Biochem J; 1980 Sep; 189(3):481-9. PubMed ID: 7213342
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma.
    Griffith MJ; Carraway T; White GC; Dombrose FA
    Blood; 1983 Jan; 61(1):111-8. PubMed ID: 6184096
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cerebral infarction in a heterozygote with variant antithrombin III.
    Arima T; Motomura M; Nishiura Y; Tsujihata M; Okajima K; Abe H; Nagataki S
    Stroke; 1992 Dec; 23(12):1822-5. PubMed ID: 1448834
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of recombinant human antithrombin III synthesized in Chinese hamster ovary cells.
    Zettlmeissl G; Conradt HS; Nimtz M; Karges HE
    J Biol Chem; 1989 Dec; 264(35):21153-9. PubMed ID: 2592368
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise.
    Bauters A; Zawadzki C; Bura A; Théry C; Watel A; Subtil D; Aiach M; Emmerich J; Jude B
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):705-10. PubMed ID: 8958394
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association of hereditary heparin co-factor II deficiency with thrombosis.
    Tran TH; Marbet GA; Duckert F
    Lancet; 1985 Aug; 2(8452):413-4. PubMed ID: 2863444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.